MedPath

ziresovir

Generic Name
ziresovir
Drug Type
Small Molecule
Chemical Formula
C22H25N5O3S
CAS Number
1422500-60-4
Unique Ingredient Identifier
XCF42D7AG4

Overview

Ziresovir is under investigation in clinical trial NCT03699202 (Anti-RSV Study in Chinese Patients (ASCENT)).

Background

Ziresovir is under investigation in clinical trial NCT03699202 (Anti-RSV Study in Chinese Patients (ASCENT)).

Indication

用于儿童呼吸道合胞病毒(RSV)引起的上呼吸道感染。

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath